Intrinsic Value of S&P & Nasdaq Contact Us

ICON Public Limited Company ICLR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • IE • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$217.20
+92.1%
Analyst Price Target
$157.44
+39.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

ICON Public Limited Company (ICLR) trades at a trailing P/E of 13.4, forward P/E of 9.2. Trailing earnings yield is 7.48%, forward earnings yield 10.91%. PEG 0.46 (Peter Lynch undervalued ≤1.0). Graham Number is $145.02.

Criteria proven by this page:

  • VALUE (80/100, Pass) — P/E is below market average (13.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.46); analyst target implies upside (+39.3%); earnings yield beats bond yields (7.48%).
  • Forward P/E 9.2 (down from trailing 13.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.46 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 7.48% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10.91% as earnings recover.
  • Analyst consensus target $157.44 (+39.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
71/100
SG Score
View full scorecard →
VALUE
80/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
→ Income
GROWTH
90/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — ICLR

Valuation Multiples
P/E (TTM)13.4
Forward P/E9.2
PEG Ratio0.46
Forward PEG0.31
P/B Ratio0.86
P/S Ratio0.98
EV/EBITDA9.3
Per Share Data
EPS (TTM)$7.75
Forward EPS (Est.)$12.33
Book Value / Share$120.65
Revenue / Share$104.72
FCF / Share$12.87
Yields & Fair Value
Earnings Yield7.48%
Forward Earnings Yield10.91%
Dividend Yield0.00%
Graham Number$145.02
SharesGrow IV$217.20 (+92.1%)
Analyst Target$157.44 (+39.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2015 19.1 0.42 5.97 2.90 -
2016 15.8 0.97 4.40 2.49 -
2017 22.0 2.32 5.20 3.52 -
2018 21.7 1.48 5.16 2.69 -
2019 24.8 1.66 5.73 3.31 -
2020 31.4 -3.85 5.57 3.68 -
2021 135.7 -2.13 2.58 3.79 -
2022 31.3 0.18 1.86 2.05 -
2023 38.0 1.87 2.52 2.86 -
2024 21.9 0.76 1.82 2.09 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $3.97 $1.57B $239.54M 15.2%
2016 $4.65 $1.67B $262.18M 15.7%
2017 $4.98 $1.76B $272.94M 15.5%
2018 $5.90 $2.6B $322.82M 12.4%
2019 $6.88 $2.81B $373.99M 13.3%
2020 $6.24 $2.8B $327.81M 11.7%
2021 $2.25 $5.48B $153.19M 2.8%
2022 $6.13 $7.74B $505.3M 6.5%
2023 $7.40 $8.12B $612.34M 7.5%
2024 $9.53 $8.28B $791.47M 9.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $12.41 $10.47 – $13.17 $7.95B $7.84B – $8.01B 11
2027 $13.42 $11.60 – $15.01 $8.27B $8.1B – $8.41B 6
2028 $14.98 $10.44 – $18.43 $8.71B $8.66B – $8.75B 5
2029 $15.69 $15.14 – $16.02 $8.94B $8.7B – $9.09B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message